Covered recipient · General Payments record
MIRKO ZUGEC
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,805.70
- Reported across 154 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $712.74 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $141.41 | 4 |
| Gilead Sciences, Inc. | $123.25 | 1 |
| Ascendis Pharma Inc | $118.91 | 1 |
| Novo Nordisk AS | $109.17 | 2 |
| EMD Serono, Inc. | $102.14 | 1 |
| Radius Health, Inc. | $99.42 | 1 |
| Corcept Therapeutics | $18.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $124.99 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225496 | CMS |
| Amgen Inc. | $6.67 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225483 | CMS |
| Amgen Inc. | $4.75 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225488 | CMS |
| Amgen Inc. | $5.00 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225490 | CMS |
| Ascendis Pharma Inc | $118.91 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133850384 | CMS |
| Corcept Therapeutics | $18.44 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117740550 | CMS |
| EMD Serono, Inc. | $102.14 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120253273 | CMS |
| Gilead Sciences, Inc. | $123.25 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133749640 | CMS |
| Novo Nordisk Inc | $17.15 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097312132 | CMS |
| Novo Nordisk Inc | $92.02 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097820125 | CMS |
| Radius Health, Inc. | $99.42 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089977426 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.